Torrent Pharmaceuticals Ltd has informed BSE that the Company has commissioned a new facility to manufacture human insulin at its Indrad manufacturing complex exclusively for supply to global healthcare major Novo Nordisk. The Company has submitted to BSE a copy of the Press Release dated November 14, 2009 titled "Torrents New Insulin Facility to produce 26 million vials pa for Novo Nordisk".
| NIFTY 
